MAR 15, 2018 09:32 AM PDT

A DNA based nanorobot to search and destroy cancer!

Science fiction film Fantastic Voyage is a well-known motion picture where miniaturized nano-submarine is injected into a comatose scientist to search and destroy his brain clot. This kind of nanomedicine may not be possible, but scientists have created a nano-sized DNA origami which transforms after encountering tumor and kill it using its payload.

a) Design and characterization of DNA origami; b) Atomic force microscopy images of DNA nanorobots in open and closed state.  Coursey: Nature Biotechnology

DNA based origami robots have been shown to sense the environment and actuate a function. However, targeted in-vivo delivery of a drug using DNA origami-based robots has never been shown until now. A team of Chinese scientists has recently published a paper in a peer-reviewed journal of Nature Biotechnology, which describes DNA based robots for targeted controlled delivery of cancer-destroying chemical in-vivo.

Most of the cancers are solid tumors which are known to rely on newly developed blood vessels for the continuous source of nutrients and oxygen for the growth of the tumor mass. Targeting these blood vessels by occlusion can initiate a cascade of the cataclysm of cells death within the tumor. Occlusion of tumor blood vessel leads to thrombus formation which is very difficult for tumor cells to overcome in the form of tumor resistance. Moreover, occlusion based therapy can be used for many different types of tumors as all of them rely on blood vessel formation.

Thrombin is a type of protease which activates platelets and form obstructive thrombosis. However, naked thrombin is short-lived and has off-site target side effects, and that is why its use is limited in cancer therapeutics. In the present paper, the team of scientists used DNA origami to protect thrombin from the harsh in-vivo denaturing environment. The release of the thrombin from DNA nanorobots was triggered only by tumor blood vessel marker, nucleolin.

First, the team used a single-stranded M13 bacteriophage DNA to make a rectangular origami sheet which was then chemically anchored with thrombin at specific sites. They did in-vitro biological tests to make sure thrombin enzyme is active within the nanorobots. Using DNA aptamers as the fasteners, they made rectangular sheet into tubular structure to surround thrombin within the hollow tube to protect against plasma fibrinogen and platelets. DNA aptamers are artificially made small oligonucleotides which can be designed to bind a specific molecule. Here in this study, scientists used DNA aptamers which could specifically bind nucleolin present on tumor blood vessels. Many in-vitro tests conducted by them showed aptamer fastener could recognize nucleolin present on actively proliferating endothelial cells of the tumor. Upon binding, aptamer reconfigured and allowed tubular structure to deliver its cargo, thrombin at the binding site. Furthermore, they used a mouse model of melanoma to show the therapeutic potential of their nanorobots. The data from those experiments shows the occlusion of the blood vessel at tumor site leading to reduced tumor burden and statistically significant survival in treated mice. In this melanoma model, DNA nanorobots not only reduced primary tumor but also decreased the metastatic score.

Note: DNA origami as nanostructure;   Courtsey: iBiology

Finally, authors suggest that this new technology in future can be used as a drug delivery mechanism for other diseases by changing the targeting moieties and loaded drug molecule.

About the Author
  • Biological research scientist by profession with passion to write about science in general.
You May Also Like
JUL 22, 2018
Cell & Molecular Biology
JUL 22, 2018
Using Nanosubmarines to Fight Tumors and Headaches
Researchers are getting closer to creating targeted therapies that are delivered directly where needed....
JUL 26, 2018
Genetics & Genomics
JUL 26, 2018
When a Cancer Gene Switches Sides
All cells carry a gene named p53, which has a vital role in shielding the body from cancer. But it can betray cells too....
AUG 14, 2018
Cancer
AUG 14, 2018
New Drug for Refractory Cutaneous T-cell Lymphoma
Mogamulizumab was approved by the FDA this month after a very successful Phase III clinical trial demonstrating its effectiveness in treating patients with challenging CTCL....
OCT 03, 2018
Cell & Molecular Biology
OCT 03, 2018
Single Cell Modified in CAR T Therapy Causes Deadly Relapse
One cell meant a very different outcome for a patient that was the recipient of a cutting-edge cancer therapy....
OCT 04, 2018
Videos
OCT 04, 2018
Zebrafish as Metastatic Cancer Model
Another Koch Institute Image Award winner from 2018 is presented in this video from MIT....
OCT 07, 2018
Videos
OCT 07, 2018
Certain Foods Encourage a Gut Microbe, and Colon Cancer
Researchers reveal more evidence that refined grains and sugars and processed meats are bad for colon health....
Loading Comments...